---
title: "\"A-Share Focus\" Pharmaceutical leader reports good performance, drug stocks boosted, Asymchem hits the upper limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284295925.md"
description: "Pharmaceutical leader WuXi AppTec released its first-quarter report, with revenue of 12.436 billion yuan, a year-on-year increase of 28.81%, and a net profit attributable to the parent company of 4.652 billion yuan, a year-on-year increase of 26.68%. The pharmaceutical sector was boosted, with Asymchem, Rundu Pharma, and TJPC hitting the daily limit, WALVAX rising by 9.2%, Baidu's stock rising by 7%, and MEDISAN rising by 6.5%"
datetime: "2026-04-28T02:04:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284295925.md)
  - [en](https://longbridge.com/en/news/284295925.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284295925.md)
---

# "A-Share Focus" Pharmaceutical leader reports good performance, drug stocks boosted, Asymchem hits the upper limit

According to a report from Economic Information Daily on the 28th, pharmaceutical leader WuXi AppTec (Shanghai: 603259) disclosed its first-quarter report, achieving revenue of 12.436 billion yuan (RMB, the same below), a year-on-year increase of 28.81%, with first-quarter revenue exceeding 10 billion yuan for the first time; it realized a net profit attributable to the parent company of 4.652 billion yuan, a year-on-year growth of 26.68%. Both operating revenue and net profit attributable to the parent company set historical highs for the same period.

The pharmaceutical sector was boosted, with Asymchem (Shenzhen: 002821), Rundu Pharma (Shenzhen: 002923), and TJPC (Shanghai: 600488) hitting the daily limit, while WALVAX (Shenzhen: 300142) rose by 9.2%, and Baidu's biotech (Shanghai: 688796) increased by 7%, and MEDISAN (Shenzhen: 002900) rose by 6.5%. (ry)

### Related Stocks

- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [600488.CN](https://longbridge.com/en/quote/600488.CN.md)
- [06821.HK](https://longbridge.com/en/quote/06821.HK.md)
- [002923.CN](https://longbridge.com/en/quote/002923.CN.md)
- [300142.CN](https://longbridge.com/en/quote/300142.CN.md)
- [002821.CN](https://longbridge.com/en/quote/002821.CN.md)
- [002900.CN](https://longbridge.com/en/quote/002900.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [688796.CN](https://longbridge.com/en/quote/688796.CN.md)
- [02315.HK](https://longbridge.com/en/quote/02315.HK.md)

## Related News & Research

- [WuXi AppTec files HKEX next-day return disclosing share repurchase for treasury shares](https://longbridge.com/en/news/290666505.md)
- [WuXi AppTec files HKEX next-day disclosure return on share repurchase for cancellation](https://longbridge.com/en/news/290800788.md)
- [Asymchem Aligns H Share Register Closure for Dividend and Shareholder Meetings](https://longbridge.com/en/news/290807877.md)
- [WuXi AppTec files HKEX next-day disclosure return on share repurchase for treasury shares](https://longbridge.com/en/news/290532976.md)
- [WuXi AppTec Completes HK$2.5 Billion H-Share Buyback for 2026 Incentive Scheme](https://longbridge.com/en/news/290031947.md)